Physician profile
Michael C Dicello
NPI 1720083173
$10,518.80
in general payments reported to CMS, 2019-2025
9 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.75 · 2021: $167 · 2022: $12.93 · 2023: $10K · 2024: $13.76 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $188 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,000.00 |
| Food and Beverage | $187.56 |
| Education | $138.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $10,058.25 | 2022-2023 | Trelegy Ellipta, Arexvy |
| Blueprint Medicines Corporation | $146.41 | 2023-2025 | Ayvakit |
| Regeneron Healthcare Solutions, INC. | $137.83 | 2021-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $76.09 | 2021-2024 | Eohilia |
| Teva Pharmaceuticals USA, INC. | $25.20 | 2021 | |
| Genentech USA, INC. | $22.24 | 2023 | Xolair |
| Pfizer INC. | $20.99 | 2021 | |
| Genzyme Corporation | $19.04 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dicello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.